Evidence map›Paper›PMID 34480001›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Calmodulin extracts the Ras family protein RalA from lipid bilayers by engagement with two membrane-targeting motifs.

Samuel G Chamberlain, Andrea Gohlke, Arooj Shafiq, Iolo J Squires, Darerca Owen, Helen R Mott

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Samuel G ChamberlainDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.ORCID 0000-0001-7184-4524
Andrea GohlkeMechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, United Kingdom.ORCID 0000-0002-5447-5453
Arooj ShafiqDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.ORCID 0000-0002-1800-9404
Iolo J SquiresDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Darerca OwenDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom; hrm28@cam.ac.uk do202@cam.ac.uk.ORCID 0000-0003-0978-5425
Helen R MottDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom; hrm28@cam.ac.uk do202@cam.ac.uk.ORCID 0000-0002-7890-7097
University of Cambridge · GBAstraZeneca (United Kingdom) · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E013228/1Biotechnology and Biological Sciences Research Council BB/P504853/1Cancer Research UKMedical Research Council MC_U117533887Wellcome Trust FC001029
6 · The paper itself

Abstract

RalA is a small GTPase and a member of the Ras family. This molecular switch is activated downstream of Ras and is widely implicated in tumor formation and growth. Previous work has shown that the ubiquitous Ca

Indexed as

Amino Acid MotifsBinding SitesCalmodulinCell MembraneHumansLipid BilayersMolecular StructureNuclear Magnetic Resonance, BiomolecularPhosphorylationProtein BindingProtein Prenylationral GTP-Binding ProteinsSerineCalmodulinLipid BilayersRALA protein, humanral GTP-Binding ProteinsSerinecalmodulinK-Rasmembranenuclear magnetic resonanceRal

Identifiers

PMID34480001
PMCPMC8433508
OpenAlexW3196806901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.